Detail of outcome
Following a public consultation on proposals for amendments to medicines legislation to simplify the information required to be included in some advertisements to prescribers and suppliers of medicines, the MHRA has decided that with effect from 1 October 2014 it will use the marketing authorisation and self-regulation to require that the short form of advertisement is not used for innovative medicines for the first two years after launch to ensure pharmacy staff have the opportunity to gain familiarity with the product. The MHRA has also gained agreement from PAGB to include a requirement that their Code of Practice will require that training materials always carry the full prescribing information.
This consultation ran from to
MHRA is asking for feedback on a proposal to simplify the information requirements for advertisements aimed at prescribers and suppliers of medicines.
This consultation seeks views on a proposal to simplify the information requirements for advertisements aimed at prescribers and suppliers of medicines.
This would be achieved by amending the Human Medicines Regulations 2012 to extend the use of an existing abbreviated advertisement format.
No changes are proposed to the requirements for advertising to the public.
Comments should be sent to MHRA by 22 April 2014. Comments received after that date will not be considered.